Overview
Ring is powering a New Era of Gene Therapy by developing Anellovectors™, the first potentially redosable and targetable gene therapy platform, by harnessing the human commensal virome.
Ring Therapeutics
.png)
Member Directory
Ring is powering a New Era of Gene Therapy by developing Anellovectors™, the first potentially redosable and targetable gene therapy platform, by harnessing the human commensal virome.